Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-a2b in patients with metastatic melanoma.
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin.
Maternal effects on offspring stress physiology in wild chimpanzees.
Nonvisualized type III endoleak masquerading as endotension: a case report.
Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.
Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophr Bull. 2019 01 01; 45(1):222-232.
View in:
PubMed
subject areas
Adolescent
Adult
Chromosomes, Human, Pair 6
Female
Genetic Association Studies
Genetic Predisposition to Disease
Gray Matter
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Parietal Lobe
Polymorphism, Single Nucleotide
Prefrontal Cortex
Psychotic Disorders
Risk
Schizophrenia
Young Adult
authors with profiles
Elliot S. Gershon